Inquiry Basket

Meningococcal Group A, C Bivalent Polysaccharide Conjugate Vaccine

Cat# : VAC-0380

Product Datasheets COA :
Cat#:  VAC-0380
Product Name:  Meningococcal Group A, C Bivalent Polysaccharide Conjugate Vaccine
Description:  This vaccine is with meningococcal A 29201 strains, 29205 strains of group C meningococcal respectively by fermentation, purification of capsular polysaccharide antigens, after polysaccharide activation, derivative with tetanus toxoid protein covalent bonding is A group of polysaccharides and protein binders and C group of polysaccharide and protein, according to A certain mixing ratio, after lyophilization in adding the suitable stabilizer.
Formulation:  Each 0. 5ml contains:Group A meningococcal capsular polysaccharide 10μg Group C meningococcal capsular polysaccharide 10μg Tetanus toxoid protein 33~120μg lactose 3~5mg sodium chloride 3. 75~4. 75mg Diluent: sterilizing water for injection
Storage:  Store and transport from 2°C to 8°C out of light.
Function:  The vaccine is used to prevent infectious diseases caused by group A and C meningococci, such as cerebrospinal meningitis septicemia (systemic infection). The vaccine does not prevent infection caused by other groups of meningococci or other pathogens that cause meningitis or septicemia
For research use only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Online Inquiry

  • Size: 100ug 500ug 1mg 5mg 10mg 100mg 500mg 1g
  • Conjugation: None R-PE APC Biotin FITC Alexa Flour Others

For more information on how our products could help advance your project, please contact us.

Contact Us


Copyright © 2024 Creative BioMart. All Rights Reserved.